Wells Fargo & Company Evolent Health, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Evolent Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 90,206 shares of EVH stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,206
Previous 91,041
0.92%
Holding current value
$1.08 Million
Previous $1.74 Million
46.61%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding EVH
# of Institutions
305Shares Held
124MCall Options Held
2.13MPut Options Held
2.64M-
Wellington Management Group LLP Boston, MA12.6MShares$151 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$131 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.69MShares$104 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.51MShares$102 Million3.36% of portfolio
-
William Blair Investment Management, LLC Chicago, IL4.94MShares$59.1 Million0.36% of portfolio
About Evolent Health, Inc.
- Ticker EVH
- Exchange NYSE
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 97,063,696
- Market Cap $1.16B
- Description
- Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...